✨ Your Portfolio is fetched and updated from zerodha.
Micro Services

Vanta Bioscience Ltd.

VANTABIO

Market Cap
₹18 Cr.
P/E
0.00

Vanta Bioscience Ltd.

  • Vanta Bioscience
  • Suvidha Infraestate
  • MIG Media Neurons
FAQs on Vanta Bioscience Ltd. Shareprice

Vanta Bioscience has given lower returns compared to its competitors.
Vanta Bioscience has grown at ~-33.97% over the last 2yrs while peers have grown at a median rate of 0.0%

Vanta Bioscience is not expensive.
Latest PE of Vanta Bioscience is 0.0, while 3 year average PE is 170.
Also latest EV/EBITDA of Vanta Bioscience is 0.0 while 3yr average is 34.45.

View FAQ's On Business
Growth Table
  • Vanta Bioscience Ltd.
  • Suvidha Infraestate
  • MIG Media Neurons
Balance Sheet
  • Vanta Bioscience Ltd.
  • Suvidha Infraestate
  • MIG Media Neurons
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Vanta Bioscience Ltd.
  • Suvidha Infraestate
  • MIG Media Neurons
Cash Flow
  • Vanta Bioscience Ltd.
  • Suvidha Infraestate
  • MIG Media Neurons
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Vanta Bioscience Ltd.
  • Suvidha Infraestate
  • MIG Media Neurons
Quarterly Results
  • Vanta Bioscience Ltd.
  • Suvidha Infraestate
  • MIG Media Neurons
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Vanta Bioscience Ltd. Financials

Vanta Bioscience balance sheet is weak and might have solvency issues

Yes, The debt of Vanta Bioscience is increasing.
Latest debt of Vanta Bioscience is ₹69.86 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹60.95 Crs.

The profit is oscillating.
The profit of Vanta Bioscience is -₹13.29 Crs for TTM, -₹2.32 Crs for Mar 2024 and -₹6.48 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vanta Bioscience latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Inventory, Accounts Receivable, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech